These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 30586505)

  • 1. Worldwide Frequencies of APOL1 Renal Risk Variants.
    Nadkarni GN; Gignoux CR; Sorokin EP; Daya M; Rahman R; Barnes KC; Wassel CL; Kenny EE
    N Engl J Med; 2018 Dec; 379(26):2571-2572. PubMed ID: 30586505
    [No Abstract]   [Full Text] [Related]  

  • 2. Association of
    Paranjpe I; Chaudhary K; Paranjpe M; O'Hagan R; Manna S; Jaladanki S; Kapoor A; Horowitz C; DeFelice N; Cooper R; Glicksberg B; Bottinger EP; Just AC; Nadkarni GN
    Clin J Am Soc Nephrol; 2020 Mar; 15(3):401-403. PubMed ID: 32079610
    [No Abstract]   [Full Text] [Related]  

  • 3. Introduction: APOL1-Associated Kidney Disease.
    Pollak MR
    Semin Nephrol; 2017 Nov; 37(6):489. PubMed ID: 29110755
    [No Abstract]   [Full Text] [Related]  

  • 4. Genetic risk of APOL1 and kidney disease in children and young adults of African ancestry.
    Reidy KJ; Hjorten R; Parekh RS
    Curr Opin Pediatr; 2018 Apr; 30(2):252-259. PubMed ID: 29406442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APOL1 nephropathy risk variants do not associate with subclinical atherosclerosis or left ventricular mass in middle-aged black adults.
    Gutiérrez OM; Limou S; Lin F; Peralta CA; Kramer HJ; Carr JJ; Bibbins-Domingo K; Winkler CA; Lewis CE; Kopp JB
    Kidney Int; 2018 Mar; 93(3):727-732. PubMed ID: 29042080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein L1 and Kidney Disease in African Americans.
    Friedman DJ; Pollak MR
    Trends Endocrinol Metab; 2016 Apr; 27(4):204-215. PubMed ID: 26947522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. APOL1 G2 risk allele-clarifying nomenclature.
    Zhang Z; Hao K; Ross MJ; Murphy B; Menon MC
    Kidney Int; 2017 Aug; 92(2):518-519. PubMed ID: 28709608
    [No Abstract]   [Full Text] [Related]  

  • 8. APOL1, Black Race, and Kidney Disease: Turning Attention to Structural Racism.
    Cerdeña JP; Tsai J; Grubbs V
    Am J Kidney Dis; 2021 Jun; 77(6):857-860. PubMed ID: 33485919
    [No Abstract]   [Full Text] [Related]  

  • 9. APOL1 Nephropathy: From Genetics to Clinical Applications.
    Friedman DJ; Pollak MR
    Clin J Am Soc Nephrol; 2021 Feb; 16(2):294-303. PubMed ID: 32616495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. APOL1 and kidney disease: new insights leading to novel therapies.
    Freedman BI
    Am J Kidney Dis; 2015 Jul; 66(1):9-11. PubMed ID: 26111904
    [No Abstract]   [Full Text] [Related]  

  • 11. APOL1-Mediated Kidney Disease.
    Hopper T; Olabisi OA
    JAMA; 2024 May; 331(19):1668-1669. PubMed ID: 38662391
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Grams ME; Surapaneni A; Ballew SH; Appel LJ; Boerwinkle E; Boulware LE; Chen TK; Coresh J; Cushman M; Divers J; Gutiérrez OM; Irvin MR; Ix JH; Kopp JB; Kuller LH; Langefeld CD; Lipkowitz MS; Mukamal KJ; Musani SK; Naik RP; Pajewski NM; Peralta CA; Tin A; Wassel CL; Wilson JG; Winkler CA; Young BA; Zakai NA; Freedman BI
    J Am Soc Nephrol; 2019 Oct; 30(10):2027-2036. PubMed ID: 31383730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic Testing for
    Kopp JB; Winkler CA
    Clin J Am Soc Nephrol; 2020 Jan; 15(1):126-128. PubMed ID: 31740572
    [No Abstract]   [Full Text] [Related]  

  • 14. Apolipoprotein L1 nephropathy risk variants associate with HDL subfraction concentration in African Americans.
    Freedman BI; Langefeld CD; Murea M; Ma L; Otvos JD; Turner J; Antinozzi PA; Divers J; Hicks PJ; Bowden DW; Rocco MV; Parks JS
    Nephrol Dial Transplant; 2011 Nov; 26(11):3805-10. PubMed ID: 21931123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of preeclampsia with infant APOL1 genotype in African Americans.
    Miller AK; Azhibekov T; O'Toole JF; Sedor JR; Williams SM; Redline RW; Bruggeman LA
    BMC Med Genet; 2020 May; 21(1):110. PubMed ID: 32434471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. APOL1 nephropathy risk variants are associated with altered high-density lipoprotein profiles in African Americans.
    Gutiérrez OM; Judd SE; Irvin MR; Zhi D; Limdi N; Palmer ND; Rich SS; Sale MM; Freedman BI
    Nephrol Dial Transplant; 2016 Apr; 31(4):602-8. PubMed ID: 26152403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An investigation of APOL1 risk genotypes and preterm birth in African American population cohorts.
    Robertson CC; Gillies CE; Putler RKB; Ng D; Reidy KJ; Crawford B; Sampson MG
    Nephrol Dial Transplant; 2017 Dec; 32(12):2051-2058. PubMed ID: 27638911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic association and gene-gene interaction analyses in African American dialysis patients with nondiabetic nephropathy.
    Bostrom MA; Kao WH; Li M; Abboud HE; Adler SG; Iyengar SK; Kimmel PL; Hanson RL; Nicholas SB; Rasooly RS; Sedor JR; Coresh J; Kohn OF; Leehey DJ; Thornley-Brown D; Bottinger EP; Lipkowitz MS; Meoni LA; Klag MJ; Lu L; Hicks PJ; Langefeld CD; Parekh RS; Bowden DW; Freedman BI;
    Am J Kidney Dis; 2012 Feb; 59(2):210-21. PubMed ID: 22119407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APOL1 Genotype, Kidney and Cardiovascular Disease, and Death in Older Adults.
    Mukamal KJ; Tremaglio J; Friedman DJ; Ix JH; Kuller LH; Tracy RP; Pollak MR
    Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):398-403. PubMed ID: 26634651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival Advantage of African American Dialysis Patients with End-Stage Renal Disease Causes Related to APOL1.
    Lertdumrongluk P; Streja E; Rhee CM; Moradi H; Chang Y; Reddy U; Tantisattamo E; Kalantar-Zadeh K; Kopp JB
    Cardiorenal Med; 2019; 9(4):212-221. PubMed ID: 30995638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.